The Pathogenic Bacteria of Deep Neck Infection in Patients with Type 1 Diabetes, Type 2 Diabetes, and Without Diabetes from Chang Gung Research Database.
Chih-Wei LuanChia-Yen LiuYao-Hsu YangMing-Shao TsaiYao-Te TsaiCheng-Ming HsuChing-Yuan WuPey-Jium ChangGeng-He ChangPublished in: Microorganisms (2021)
Deep neck infection (DNI) is a lethal emergent condition. Patients with types 1 and 2 diabetes mellitus (T1DM and T2DM, respectively) are predisposed to DNI and have poorer prognoses. The mainstay of the treatment is surgical drainage and antibiotics; however, the pathogenic bacteria of T1DM-DNI have not been studied before. We obtained the data of 8237 patients with DNI who were hospitalized from 2004 to 2015 from the Chang Gung Research Database, which contains multi-institutional medical records in Taiwan. Using diagnostic codes, we classified them into T1DM-DNI, T2DM-DNI, and non-DM-DNI and analyzed their pathogenic bacteria, disease severity, treatment, and prognosis. The top three facultative anaerobic or aerobic bacteria of T1DM-DNI were Klebsiella pneumoniae (KP, 40.0%), Viridans Streptococci (VS, 22.2%), and methicillin-sensitive Staphylococcus aureus (MSSA, 8.9%), similar for T2DM (KP, 32.2%; VS, 23.3%; MSSA, 9.5%). For non-DM-DNI, it was VS (34.6%), KP (9.8%), and coagulase-negative Staphylococci (8.7%). The order of anaerobes for the three groups was Peptostreptococcus micros, Prevotella intermedia, and Peptostreptococcus anaerobius. Patients with T1DM-DNI and T2DM-DNI had higher white blood cell (WBC) counts and C-reactive protein (CRP) levels, more cases of surgery, more cases of tracheostomy, longer hospital stays, more mediastinal complications, and higher mortality rates than those without DM-DNI. Patients in the death subgroup in T1DM-DNI had higher WBC counts, band forms, and CRP levels than those in the survival subgroup. Patients with DM-DNI had more severe disease and higher mortality rate than those without DM-DNI. KP and Peptostreptococcus micros are the leading pathogens for both patients with T1DM-DNI and those with T2DM-DNI. Clinicians should beware of high serum levels of infection markers, which indicate potential mortality.
Keyphrases
- glycemic control
- type diabetes
- staphylococcus aureus
- healthcare
- escherichia coli
- stem cells
- risk factors
- minimally invasive
- cardiovascular disease
- adipose tissue
- palliative care
- randomized controlled trial
- metabolic syndrome
- multidrug resistant
- early onset
- clinical trial
- insulin resistance
- bone marrow
- lymph node
- cystic fibrosis
- methicillin resistant staphylococcus aureus
- study protocol
- atrial fibrillation
- pseudomonas aeruginosa
- adverse drug
- cell therapy
- open label
- antimicrobial resistance
- acute respiratory distress syndrome
- human health
- biofilm formation
- microbial community
- patient reported outcomes